Grifols SA (GRFS)

21.80
0.06 0.27
NASDAQ : Health Care
Prev Close 21.86
Open 21.90
Day Low/High 21.76 / 21.90
52 Wk Low/High 14.07 / 18.04
Volume 63.50K
Avg Volume 748.20K
Exchange NASDAQ
Shares Outstanding 683.26M
Market Cap 15.26B
EPS 0.80
P/E Ratio 43.78
Div & Yield 0.33 (1.50%)

Latest News

Grifols Strengthens Position As Global Provider Of Diagnostic Testing Solutions With Five-Year Extension Of OraSure Technologies Agreement And A New Manufacturing Facility

- Longstanding relationship between companies fortified by multi-year contract extension

Hologic Completes Divestiture Of Blood Screening Business

- Strengthens Efforts to Build a Sustainable Growth Company -

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic and Grifols have worked together since 1998 building a blood screening business, and now Hologic will sell its share to Grifols.

Grifols Immunohematology Center Laboratory In San Marcos, Texas, Has Expanded Its Testing Capabilities To Include Basic And Advanced Serological And Molecular Testing. (Graphic: Business Wire)

Grifols Immunohematology Center Laboratory In San Marcos, Texas, Has Expanded Its Testing Capabilities To Include Basic And Advanced Serological And Molecular Testing. (Graphic: Business Wire)

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a global healthcare company, has expanded the menu of tests offered at the Grifols Immunohematology Center laboratory to include basic and advanced serological and molecular...

5 Big Dividend Stocks Billionaire John Paulson Loves

5 Big Dividend Stocks Billionaire John Paulson Loves

Here's a closer look at five dividend stocks that Paulson & Co. owned in the most recently reported quarter.

Grifols Opens Diagnostic Training Center in Dubai

Grifols Opens Diagnostic Training Center in Dubai

-The new center, part of Grifols growing Diagnostic business, will train laboratory technicians, engineers, and specialists on Grifols systems and laboratory best practices.

3 Stocks Pulling The Health Services Industry Downward

3 Stocks Pulling The Health Services Industry Downward

TheStreet highlights 3 stocks pushing the drugs industry lower today.

FDA Approves Use Of The Procleix Zika Virus Assay From Hologic And Grifols To Screen The U.S. Blood Supply Under An IND Study Protocol

FDA Approves Use Of The Procleix Zika Virus Assay From Hologic And Grifols To Screen The U.S. Blood Supply Under An IND Study Protocol

­­­­­--Blood banks will use the new test, co-developed by Hologic and Grifols, to screen donated blood in potential endemic areas of the US--

3 Stocks Pushing The Health Services Industry Higher

3 Stocks Pushing The Health Services Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Singulex Announces A $50 Million Investment By Grifols For A 20% Stake In The Company

Singulex Announces A $50 Million Investment By Grifols For A 20% Stake In The Company

Grifols investment to Shape the Future of Blood Screening

3 Health Services Stocks Driving The Industry Higher

3 Health Services Stocks Driving The Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Weak On High Volume: Grifols (GRFS)

Weak On High Volume: Grifols (GRFS)

Trade-Ideas LLC identified Grifols (GRFS) as a weak on high relative volume candidate

8 Biotech Stocks That Should Be in Your Portfolio Right Now

8 Biotech Stocks That Should Be in Your Portfolio Right Now

Which biotech companies are the best investments for your portfolio? Consider buying any of these eight A+ rated stocks.

3 Stocks Raising The Health Services Industry Higher

3 Stocks Raising The Health Services Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

Grifols (GRFS) Strong On High Relative Volume Today

Grifols (GRFS) Strong On High Relative Volume Today

Trade-Ideas LLC identified Grifols (GRFS) as a strong on high relative volume candidate

Strong On High Relative Volume: Grifols (GRFS)

Strong On High Relative Volume: Grifols (GRFS)

Trade-Ideas LLC identified Grifols (GRFS) as a strong on high relative volume candidate

First Week Of GRFS February 2016 Options Trading

First Week Of GRFS February 2016 Options Trading

Investors in Grifols SA, Barcelona saw new options become available this week, for the February 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 217 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

3 Stocks Advancing The Drugs Industry

3 Stocks Advancing The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Improving Performance Of The Drugs Industry

3 Stocks Improving Performance Of The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Driving The Health Care Sector Higher

3 Stocks Driving The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.